FFM
Forum Financial Management Portfolio holdings
AUM
$6.57B
This Quarter Return
-13.07%
1 Year Return
+12.97%
3 Year Return
+40.49%
5 Year Return
–
10 Year Return
–
AUM
$1.99B
AUM Growth
-$87.4M
(-4.2%)
Cap. Flow
+$196M
Cap. Flow
% of AUM
9.87%
Top 10 Holdings %
Top 10 Hldgs %
75.85%
Holding
676
New
70
Increased
251
Reduced
127
Closed
96
Top Buys
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
$47.3M |
| 2 |
Dimensional US Marketwide Value ETF
DFUV
|
$42.8M |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
$39.5M |
| 4 |
Dimensional US Targeted Value ETF
DFAT
|
$12.4M |
| 5 |
iShares National Muni Bond ETF
MUB
|
$8.12M |
Top Sells
| 1 |
DNMR
Danimer Scientific, Inc.
DNMR
|
$1.58M |
| 2 |
AT&T
T
|
$1.1M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$1.09M |
| 4 |
Intel
INTC
|
$920K |
| 5 |
iShares TIPS Bond ETF
TIP
|
$885K |
Sector Composition
| 1 | Healthcare | 8.96% |
| 2 | Financials | 6.1% |
| 3 | Technology | 5.02% |
| 4 | Energy | 1.78% |
| 5 | Consumer Discretionary | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Salesforce
CRM
$245B
| $1.27M | 0.06% |
7,690
+1,389
| +22% | +$229K |
|
102
Novo Nordisk
NVO
$252B
| $1.25M | 0.06% |
22,490
| – | – |
|
103
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| $1.25M | 0.06% |
+50,674
| New | +$1.25M |
|
104
Zoetis
ZTS
$67.6B
| $1.24M | 0.06% |
7,235
+34
| +0.5% | +$5.85K |
|
105
Thermo Fisher Scientific
TMO
$183B
| $1.22M | 0.06% |
2,248
+3
| +0.1% | +$1.63K |
|
106
Allstate
ALL
$53.9B
| $1.2M | 0.06% |
9,502
-4
| -0% | -$507 |
|
107
Vanguard Growth ETF
VUG
$185B
| $1.2M | 0.06% |
5,378
-1,560
| -22% | -$348K |
|
108
BancFirst
BANF
$4.45B
| $1.18M | 0.06% |
+12,349
| New | +$1.18M |
|
109
White Mountains Insurance
WTM
$4.56B
| $1.15M | 0.06% |
924
+214
| +30% | +$267K |
|
|
110
Intel
INTC
$105B
| $1.14M | 0.06% |
30,488
-24,582
| -45% | -$920K |
|
111
Constellation Brands
STZ
$25.8B
| $1.13M | 0.06% |
4,858
+337
| +7% | +$78.5K |
|
112
Norfolk Southern
NSC
$62.4B
| $1.12M | 0.06% |
4,925
| – | – |
|
113
IBM
IBM
$227B
| $1.11M | 0.06% |
7,870
+166
| +2% | +$23.4K |
|
114
Takeda Pharmaceutical
TAK
$47.8B
| $1.1M | 0.06% |
78,149
+317
| +0.4% | +$4.45K |
|
115
Linde
LIN
$221B
| $1.08M | 0.05% |
3,768
+305
| +9% | +$87.7K |
|
116
Texas Instruments
TXN
$178B
| $1.07M | 0.05% |
6,940
-175
| -2% | -$26.9K |
|
117
Accenture
ACN
$158B
| $1.07M | 0.05% |
3,836
+226
| +6% | +$62.7K |
|
118
Goldman Sachs
GS
$221B
| $1.06M | 0.05% |
3,561
-175
| -5% | -$52K |
|
119
Cigna
CI
$80.2B
| $1.05M | 0.05% |
3,996
+378
| +10% | +$99.6K |
|
120
Chemung Financial Corp
CHMG
$256M
| $1.05M | 0.05% |
22,368
| – | – |
|
121
Becton Dickinson
BDX
$54.3B
| $1.04M | 0.05% |
4,221
-142
| -3% | -$35K |
|
122
Citigroup
C
$175B
| $1.03M | 0.05% |
22,313
-3,079
| -12% | -$142K |
|
123
ASML
ASML
$290B
| $1.01M | 0.05% |
2,124
+30
| +1% | +$14.3K |
|
124
Chubb
CB
$111B
| $993K | 0.05% |
5,049
+268
| +6% | +$52.7K |
|
125
Ericsson
ERIC
$26.2B
| $992K | 0.05% |
134,043
| – | – |
|